Published by Iain Gilbert on 5th September 2022
(Sharecast News) - Drugmaker AstraZeneca said on Monday that its biliary tract cancer treatment had been granted US approval to be used as the first immunotherapy regimen for patients with the disease.
URL: http://www.digitallook.com/dl/news/story/32936761/...